Usfda

Articles Galleries Videos
  • generic tablets, diabetes medication, green signal to sun pharma from usfda, Usfda

    Green signal to Sun Pharma from USFDA 12 July 2013

    Sun Pharma can now sell its generic diabetic medication, Repaglinide tablets. The United States Food and Drug Administration (USFDA) offered the pharmaceutical company permission to market Repaglinide exclusively in the US for 180 days. The generic version of Repaglinide tablets...

    Keywords: genetic drugs, generic tablets, Repaglinide, diabetes tablets

    Read More
    generic drugs, generic drugs, dr reddy s launches generic version of ibandronate sodium tablets, Usfda

    Dr Reddy’s launches generic version of Ibandronate Sodium tablets 03 July 2012

    It has been revealed in a report that Dr. Reddy's Laboratories has formally launched the Ibandrobate Sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market. It was earlier reported that the pharma giant received...

    Keywords: ibrandronate sodium tablets, USFDA, ibrandronate sodium tablets, osteporosis

    Read More